Contract Testing Laboratories

Contract analytical, microbiological, and stability laboratories — running compendial and validated methods, and defending data integrity for their clients.

Assess your quality system →Explore GxP disciplines →
WHAT THIS SECTOR DOES

Contract testing laboratories run analytical, microbiological, stability, and bioanalytical testing for sponsors, manufacturers, and CROs. They release raw materials and finished product, support stability programs, and generate the compendial data on which a batch disposition or a submission depends. The lab’s result is often the last check before product reaches a patient.

REGULATORY LANDSCAPE

GMP testing labs work to 21 CFR 211 subpart I (laboratory controls) and the USP compendia; GLP-regulated studies to 21 CFR Part 58 and OECD GLP; and many labs additionally carry ISO/IEC 17025 accreditation. Method validation and transfer follow ICH Q2 and USP general chapters, and every result lives under 21 CFR Part 11 data-integrity expectations.

THE OVERSIGHT MODEL

The customer qualifies and audits the lab and remains responsible for the decision made on the lab’s data; the lab is responsible for method suitability, competent execution, and the integrity of the result. A quality/technical agreement defines method ownership, OOS handling, and data return — and the lab must be able to reconstruct any reported result from its raw data on demand.

78
Standards decoded
4
GxP disciplines
WHAT QUALITY MEANS HERE
01

Method validation & transfer

Demonstrating that a method is suitable and performs the same at the contract lab as at the originator (ICH Q2, USP) before any reportable result is generated.

02

OOS & OOT investigations

Sound out-of-specification and out-of-trend handling — the single most inspected laboratory process, where weak investigations invalidate the result.

03

Data integrity & raw-data traceability

Audit trails, second-person review, and the ability to reconstruct every reported value from instrument raw data (ALCOA+).

04

Compendial & microbiological control

Correct application of USP methods and microbiological limits, including environmental and sterility testing where in scope.

GXP DISCIPLINES IN THIS SECTOR
GMPGood Manufacturing PracticeGLPGood Laboratory PracticeGCLPGood Clinical Laboratory PracticeQMSQuality Management Systems
STANDARDS SPEQ DECODES · 78
Open the full library →
21 CFR Part 211FDAHIGH INSPECTION RISK
Current Good Manufacturing Practice for Finished Pharmaceuticals
21 CFR Part 210FDA
Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs — General
21 CFR Part 820FDAHIGH INSPECTION RISK
Quality System Regulation (QSR) for Medical Devices
FDA Aseptic Processing GuidanceFDAHIGH INSPECTION RISK
Guidance for Industry — Sterile Drug Products Produced by Aseptic Processing
FDA Process Validation Guidance (2011)FDA
Guidance for Industry — Process Validation: General Principles and Practices
EU GMP Annex 1 (2022)EMAHIGH INSPECTION RISK
Manufacture of Sterile Medicinal Products
EU GMP Annex 15EMA
Qualification and Validation
EU GMP Annex 2EMA
Manufacture of Biological Active Substances and Medicinal Products for Human Use
ICH Q5A(R2)ICH
Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
ICH Q9(R1)ICH
Quality Risk Management
ICH Q10ICH
Pharmaceutical Quality System
ICH Q8(R2)ICH
Pharmaceutical Development
ICH Q11ICH
Development and Manufacture of Drug Substances (Chemical and Biotechnological/Biological Entities)
ICH Q12ICH
Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
ICH Q7ICH
Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
USP <1116>USPHIGH INSPECTION RISK
Microbiological Control and Monitoring of Aseptic Processing Environments
USP <1117>USP
Microbiological Best Laboratory Practices
USP <1058>USP
Analytical Instrument Qualification
USP <61>/<62>USP
Microbiological Examination of Nonsterile Products
ISO 14644-1ISO
Cleanrooms and Associated Controlled Environments — Classification of Air Cleanliness by Particle Concentration
ISO 14644-2ISO
Cleanrooms and Associated Controlled Environments — Monitoring to Provide Evidence of Cleanroom Performance
ISO 9001:2015ISO
Quality Management Systems — Requirements
ISO 13485:2016ISO
Medical Devices — Quality Management Systems — Requirements for Regulatory Purposes
PIC/S PE 009-16PIC/S
Guide to Good Manufacturing Practice for Medicinal Products
ICH E6(R3)ICHHIGH INSPECTION RISK
Good Clinical Practice (GCP)
ICH E8(R1)ICH
General Considerations for Clinical Studies
21 CFR Part 312FDAHIGH INSPECTION RISK
Investigational New Drug Application (IND)
21 CFR Part 50FDAHIGH INSPECTION RISK
Protection of Human Subjects (Informed Consent)
21 CFR Part 56FDA
Institutional Review Boards (IRBs)
Regulation (EU) 536/2014EMAHIGH INSPECTION RISK
Clinical Trials Regulation (CTR)
21 CFR Part 58FDAHIGH INSPECTION RISK
Good Laboratory Practice for Nonclinical Laboratory Studies
OECD GLP PrinciplesOECD
OECD Principles of Good Laboratory Practice
Directive 2004/10/ECEC
Harmonisation of Laws Relating to the Application of GLP
ICH E2AICH
Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
MHLW Ordinance No. 179PMDA
Japan GMP for Drugs and Quasi-drugs
ANVISA RDC 658/2022ANVISA
Brazilian Good Manufacturing Practices for Medicines
NOM-059-SSA1-2015COFEPRIS
Mexican Good Manufacturing Practices for Medicines
ANMAT Disposición 4159/2023ANMAT
Argentine GMP Guide for Medicines
Resolución 1160 de 2016INVIMA
Colombian Good Manufacturing Practices for Medicines
DS 021-2018-SADIGEMID
Peruvian GMP Manual for Pharmaceutical Products
Norma Técnica N° 127ISP Chile
Chilean Good Manufacturing Practices
China GMP (2010 Revision)NMPA
Good Manufacturing Practice for Drugs (China)
Revised Schedule M (2023)CDSCO
India GMP — Schedule M, Drugs and Cosmetics Rules
Health Canada GUI-0001Health Canada
Good Manufacturing Practices Guide for Drug Products
TGA Manufacturing PrinciplesTGA
Australian GMP — Manufacturing Principles (PIC/S Guide)
PDA TR No. 22PDA
Process Simulation for Aseptically Filled Products
ICH Q3D(R2)ICH
Guideline for Elemental Impurities
ISO 14971:2019ISO
Medical Devices — Application of Risk Management to Medical Devices
WHO GCLP (2009)WHO
Good Clinical Laboratory Practice (GCLP)
21 CFR Part 117FDAHIGH INSPECTION RISK
Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food
21 CFR Part 111FDAHIGH INSPECTION RISK
Current Good Manufacturing Practice for Dietary Supplements
Codex CXC 1-1969Codex
General Principles of Food Hygiene
ISO 22000:2018ISO
Food safety management systems — Requirements for any organization in the food chain
21 CFR Part 226FDA
Current Good Manufacturing Practice for Type A Medicated Articles
21 CFR Part 225FDA
Current Good Manufacturing Practice for Medicated Feeds
Regulation (EU) 2019/6EC
Veterinary Medicinal Products
ISO 22716:2007ISO
Cosmetics — Good Manufacturing Practices (GMP): Guidelines on Good Manufacturing Practices
21 CFR Part 1271FDA
Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
21 CFR Part 606FDA
Current Good Manufacturing Practice for Blood and Blood Components
Regulation (EU) 2017/745ECHIGH INSPECTION RISK
Medical Device Regulation (MDR)
21 CFR Part 121FDA
Mitigation Strategies to Protect Food Against Intentional Adulteration
21 CFR Part 507FDA
Current Good Manufacturing Practice and Preventive Controls for Food for Animals
VICH GL3(R)VICH
Stability Testing of New Veterinary Drug Substances and Medicinal Products
MoCRA (FD&C Act Ch. VI)FDA
Modernization of Cosmetics Regulation Act of 2022
Regulation (EC) No 1223/2009EC
EU Cosmetic Products Regulation
21 CFR Part 700FDA
Cosmetics — General
FD&C Act §503AFDAHIGH INSPECTION RISK
Pharmacy Compounding — Conditions for Exemption
FD&C Act §503BFDAHIGH INSPECTION RISK
Outsourcing Facilities — Registration and cGMP
USP <795>USPHIGH INSPECTION RISK
Pharmaceutical Compounding — Nonsterile Preparations
USP <797>USPHIGH INSPECTION RISK
Pharmaceutical Compounding — Sterile Preparations
USP <800>USPHIGH INSPECTION RISK
Hazardous Drugs — Handling in Healthcare Settings
State Pharmacy Practice ActsState Boards of PharmacyHIGH INSPECTION RISK
State Pharmacy Practice Acts and Compounding Regulations
21 CFR Part 1301DEA
Registration of Manufacturers, Distributors and Dispensers of Controlled Substances
Ph. Eur.EDQMHIGH INSPECTION RISK
European Pharmacopoeia
CEP (EDQM Certification)EDQM
Certificate of Suitability to the Monographs of the European Pharmacopoeia
IPEC-PQG GMP Guide (v5, 2022)IPECHIGH INSPECTION RISK
Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients
ISO/IEC 17025:2017ISO
General requirements for the competence of testing and calibration laboratories
ILAC MRAILAC
ILAC Mutual Recognition Arrangement
WHERE QUALITY FAILS
  • Invalidated or unreliable results from methods that were never properly transferred
  • Out-of-specification results closed without scientifically sound investigation
  • Audit-trail gaps that prevent reconstruction of a reported result
  • Contamination or handling errors in the microbiology or sterility suite
KEY REGULATORY BODIES
FDAEMAICHUSPISOPIC/SOECDECPMDAANVISACOFEPRISANMATINVIMADIGEMIDISP ChileNMPACDSCOHealth CanadaTGAPDAWHOCodexVICHState Boards of PharmacyDEAEDQMIPECILAC

Derived from the 78 standards SPEQ decodes for this sector.

REGULATED INDUSTRIES
The product industries this sector serves →
THE SPEQ FRAMEWORK
Regulatory intelligence → execution → maturity →
Weekly Briefing

Intelligence for Contract Testing Laboratories

The enforcement actions, guidance, and quality signals that shape sponsor–provider oversight — curated for Contract Testing Laboratories and delivered free each week.

Read a past issue →